該当箇所へ

Cell Therapies

CAR-T Cells & TCRs

With purpose-built functionalities for the design and evaluation of large panels of cell-based therapeutic modalities for novel immunotherapies, such as chimeric antigen receptors T cells (CAR-T), T Cell Receptor Technology (TCRs), and antibody TCR-mimetics, Genedata Biologics enables the systematic engineering, production, and testing of novel therapeutic modalities. The platform streamlines the full process from design, generation, testing, and validation, to developability and manufacturability assessments. By directly integrating with laboratory equipment, it fully automates sample handling and testing procedures. An integrated database and tools support screening and engineering of a variety of TCR-based formats (e.g., dsTCR, TCR-scFv, bispecific TCRs).